Skip to main content

Neurodevelopmental outcome in full‐term newborns with refractory neonatal seizures

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Abstract

Aim:  This retrospective study describes the prognosis of full‐term newborns with refractory neonatal seizures, comparing the need for treatment with two versus three or more antiepileptic drugs.

Methods:  We reviewed our database (January 2002–December 2007) to include newborns with refractory neonatal seizures and abnormal electroencephalogram. Group A consisted of 17 newborns with two antiepileptic drugs. Group B consisted of 29 newborns with three or more antiepileptic drugs. Outcome was determined at 2 years of age using the Dutch Bayley Scales of Infant Development or a neurodevelopmental classification scheme.

Results:  Group A and group B were comparable regarding to a variety of demographic and aetiologic factors. Thirteen newborns died before 2 years of age and one was lost to follow‐up. Normal development at 2 years of age was found in 50% and 5% for group A and B, respectively. Severe neurodevelopmental delay at 2 years of age was found in 30% and 68% for group A and B, respectively.

Conclusion:  The number of antiepileptic drugs probably reflects increased seizure burden and is – in that way – related to poor outcome. This may be useful information for early prediction of adverse neurological outcome in the first days of life.

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1651-2227.2011.02528.x

Affiliations: 1:  Department of Pediatrics and Neonatology, Máxima Medical Center, Veldhoven, The Netherlands 2:  Department of Medical Psychology, Máxima Medical Center, Veldhoven, The Netherlands

Publication date: April 1, 2012

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more